Sodium thiosulfate mitigates PM2.5-induced cardiotoxicity by preservation of mitochondrial function

IF 2.1 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Bhavana Sivakumar, Gino A. Kurian
{"title":"Sodium thiosulfate mitigates PM2.5-induced cardiotoxicity by preservation of mitochondrial function","authors":"Bhavana Sivakumar,&nbsp;Gino A. Kurian","doi":"10.1111/fcp.70010","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Exposure to PM<sub>2.5</sub> triggers changes in myocardial structure and function, leading to a decline in the ability of heart to withstand further oxidative stress. This manuscript addresses the absence of a endogenous agent capable of counteracting the cardiac toxicity associated with PM<sub>2.5</sub> exposure. Consequently, we investigated the potential of sodium thiosulfate (STS) to elevate thiosulfate levels, given its known antioxidant, anti-inflammatory, metal chelation, and mitochondrial preservation properties, in order to mitigate PM<sub>2.5</sub> induced cardiac damage.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Female Wistar rats were exposed to PM<sub>2.5</sub> (250 μg/m<sup>3</sup>) for 3 hours daily for 21 days, after which their hearts were excised and mounted on Langendorff apparatus for ischemia-reperfusion (IR) induction. We implemented both preventive and curative investigation protocols for STS: the preventive group received STS thrice weekly for 3 weeks during the exposure regimen, while the curative group received STS after 21 days of PM<sub>2.5</sub> exposure for 3 weeks (thrice per week).</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Treatment with STS exhibited cardioprotective potential against the detrimental effects of PM<sub>2.5</sub> exposure, as evidenced by improved cardiac hemodynamic performance, reduced tissue damage, attenuation of structural remodeling associated with hypertrophy and fibrosis, and a significant reduction in metal deposition. Moreover, it demonstrated an ability to enhance the resilience against IR. Cellular and subcellular level analyses revealed improved mitochondrial function. The protective efficacy of STS was more significant when administered as a preventive measure compared to its curative application.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>In summary, our results indicate that STS effectively alleviates PM<sub>2.5</sub>-induced toxicity due to its antioxidative, metal-chelating, and preservation of mitochondrial function capabilities.</p>\n </section>\n </div>","PeriodicalId":12657,"journal":{"name":"Fundamental & Clinical Pharmacology","volume":"39 3","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fundamental & Clinical Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/fcp.70010","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Exposure to PM2.5 triggers changes in myocardial structure and function, leading to a decline in the ability of heart to withstand further oxidative stress. This manuscript addresses the absence of a endogenous agent capable of counteracting the cardiac toxicity associated with PM2.5 exposure. Consequently, we investigated the potential of sodium thiosulfate (STS) to elevate thiosulfate levels, given its known antioxidant, anti-inflammatory, metal chelation, and mitochondrial preservation properties, in order to mitigate PM2.5 induced cardiac damage.

Methods

Female Wistar rats were exposed to PM2.5 (250 μg/m3) for 3 hours daily for 21 days, after which their hearts were excised and mounted on Langendorff apparatus for ischemia-reperfusion (IR) induction. We implemented both preventive and curative investigation protocols for STS: the preventive group received STS thrice weekly for 3 weeks during the exposure regimen, while the curative group received STS after 21 days of PM2.5 exposure for 3 weeks (thrice per week).

Results

Treatment with STS exhibited cardioprotective potential against the detrimental effects of PM2.5 exposure, as evidenced by improved cardiac hemodynamic performance, reduced tissue damage, attenuation of structural remodeling associated with hypertrophy and fibrosis, and a significant reduction in metal deposition. Moreover, it demonstrated an ability to enhance the resilience against IR. Cellular and subcellular level analyses revealed improved mitochondrial function. The protective efficacy of STS was more significant when administered as a preventive measure compared to its curative application.

Conclusion

In summary, our results indicate that STS effectively alleviates PM2.5-induced toxicity due to its antioxidative, metal-chelating, and preservation of mitochondrial function capabilities.

硫代硫酸钠通过保存线粒体功能减轻pm2.5诱导的心脏毒性
暴露在PM2.5中会引发心肌结构和功能的变化,导致心脏承受进一步氧化应激的能力下降。这篇论文解决了缺乏内源性药物能够抵消与PM2.5暴露相关的心脏毒性的问题。因此,我们研究了硫代硫酸钠(STS)提高硫代硫酸钠水平的潜力,鉴于其已知的抗氧化、抗炎、金属螯合和线粒体保存特性,以减轻PM2.5引起的心脏损伤。方法雌性Wistar大鼠每天暴露于PM2.5 (250 μg/m3)中3 h,连续21 d,切除心脏,置于Langendorff仪上进行缺血再灌注诱导。我们对STS实施了预防和治疗两种调查方案:在暴露方案中,预防组每周接受3次STS治疗,而治疗组在PM2.5暴露21天后接受3周STS治疗(每周3次)。结果通过改善心脏血流动力学性能、减少组织损伤、减轻与肥厚和纤维化相关的结构重塑以及显著减少金属沉积,STS治疗对PM2.5暴露的有害影响具有心脏保护潜力。此外,它还显示出增强抗IR弹性的能力。细胞和亚细胞水平分析显示线粒体功能改善。与治疗应用相比,STS作为预防措施的保护效果更为显著。综上所述,我们的研究结果表明,STS通过其抗氧化、金属螯合和线粒体功能保护能力,有效减轻了pm2.5引起的毒性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.30
自引率
6.90%
发文量
111
审稿时长
6-12 weeks
期刊介绍: Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. Original articles, short communications and reviews are published on all aspects of experimental and clinical pharmacology including: Antimicrobial, Antiviral Agents Autonomic Pharmacology Cardiovascular Pharmacology Cellular Pharmacology Clinical Trials Endocrinopharmacology Gene Therapy Inflammation, Immunopharmacology Lipids, Atherosclerosis Liver and G-I Tract Pharmacology Metabolism, Pharmacokinetics Neuropharmacology Neuropsychopharmacology Oncopharmacology Pediatric Pharmacology Development Pharmacoeconomics Pharmacoepidemiology Pharmacogenetics, Pharmacogenomics Pharmacovigilance Pulmonary Pharmacology Receptors, Signal Transduction Renal Pharmacology Thrombosis and Hemostasis Toxicopharmacology Clinical research, including clinical studies and clinical trials, may cover disciplines such as pharmacokinetics, pharmacodynamics, pharmacovigilance, pharmacoepidemiology, pharmacogenomics and pharmacoeconomics. Basic research articles from fields such as physiology and molecular biology which contribute to an understanding of drug therapy are also welcomed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信